Clinical Trials Browser

Interventional × dupilumab × Thoracic × Clear all

NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06088771 2025-05-08

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06743581 2024-12-20

Dupi-Cemi

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung